Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare ...

GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, and Quest Diagnostics , a leading provider of diagnostic information services, today announced the ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions ...

1 The latest Quest Diagnostics Drug Testing Index report highlights key trends that demonstrate the relevance of our product to U.S. employers. Marijuana positivity rates in the general U.S. workforce ...

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

The Europe In Vitro Diagnostics (IVD) market plays a crucial role in the region’s healthcare landscape, encompassing a wide range of diagnostic tests and technologies used for disease detection, ...

Global in vitro diagnostics (IVD) market will reach $148,393.3 million by 2031, growing by 6.3% annually over 2021-2031. The global in vitro diagnostics (IVD) market encompasses a wide range of ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

As a key distributor, IVY Diagnostics is playing an integral role in expanding the adoption of INBS' Intelligent Fingerprinting Drug Testing Solution across Europe and the Middle East, with a ...

Intelligent Bio Solutions partners with IVY Diagnostics to expand fingerprint drug testing in Europe, the Middle East, and Italy. Europe’s drug screening market could reach $3.6B by 2030 ...

University Hospitals will continue to provide all inpatient and select outpatient testing from its hospital-based labs. About Quest Diagnostics Quest Diagnostics works across the healthcare ...